Oppenheimer Reiterates ‘Outperform’ Rating on Abbott Laboratories (ABT)
Abbott Laboratories (NYSE:ABT) is one of the top 10 defensive stocks to consider in a volatile market. On July 3,…
Tag: Oppenheimer
Oppenheimer Reaffirms DexCom Buy Rating Amid HHS Wearables Push
DexCom, Inc. (NASDAQ:DXCM) ranks among the best fundamental stocks to buy according to hedge funds. Oppenheimer reaffirmed its $95 price…
Oil Could Hit $60 by End of Year: Goldman's Oppenheimer
Peter Oppenheimer, chief global equity strategist at Goldman Sachs, discusses the outlook for oil markets following a truce in the…
Oppenheimer Increases Snowflake (SNOW) PT, Maintains Outperform Rating
Snowflake Inc. (NASDAQ:SNOW) is one of the 10 tech stocks on Wall Street’s radar right now. On June 6, Oppenheimer…
Oppenheimer Downgrades Prothena Corporation (NASDAQ:PRTA) to Perform from Outperform
Oppenheimer downgraded Prothena Corporation plc (NASDAQ:PRTA) to Perform from Outperform on May 27 without a price target. This rating update…
Goldman's Oppenheimer: 'Growing Opportunities' in Europe
Peter Oppenheimer, chief global equity strategist at Goldman Sachs, says the prospect of looser monetary and fiscal policy in Europe…